Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BLUE

Recent news which mentions BLUE

< Previous 1 2 3 4 5 6 7 8 9 Next >
bluebird bio Earnings Preview
Tickers BLUE
Tags Market News Benzinga Earnings
From Benzinga
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is A Major Moment For Drug Development
Tickers BLUE COYA GOVX LLY
Tags General News LLY
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Tickers AMGN BLUE IBB LLY
Tags News LLY AMGN
From Benzinga
Analyst Expectations for bluebird bio's Future
Tickers BLUE
Tags Market News Benzinga Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Tickers ACMR ADVM ALLK ANET
Tags NS KRP APAM
From Benzinga
1 Beaten-Down Stock That Has a Lot to Prove in 2023
Tickers BLUE CRSP VRTX
Tags Market News VRTX BLUE
From Motley Fool
What 4 Analyst Ratings Have To Say About bluebird bio
Tickers BLUE
Tags Market News Benzinga Analyst Ratings
From Benzinga
Skechers To Rally 40%? Here Are 10 Other Analyst Forecasts For Monday
Tickers AAPL ALLY BANF BLUE
Tags BANF QCOM Price Target
From Benzinga
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Tickers BLUE CRSP VRTX
Tags BLUE CRSP Recent Press Releases
From Motley Fool
Tesla, Amazon, bluebird, Netflix, Discover Financial: Why These 5 Stocks Are Drawing Investors' Attention Today
Tickers AMZN BLUE DFS EVS
Tags TSLA e/commerce BLUE
From Benzinga
PNC Financial, bluebird bio And Other Big Stocks Moving Lower On Wednesday
Tickers ARQQ ARVL BHG BLUE
Tags big losers MARA YOU
From Benzinga
Why Is Zomedica (ZOM) Stock Up Today?
Tickers BLUE FUV MRNA ZOM
Tags BLUE MRNA ZOM
From InvestorPlace
Why Bluebird Bio (BLUE) Stock Is Getting Hammered
Tickers BLUE
Tags Market News Benzinga News
From Benzinga
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
Tickers BLUE FUV MRNA RDN
Tags Market News RDN FUV
From InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Tickers BLUE MRNA
Tags ^IXIC BLUE Recent Press Releases
From Motley Fool
Why is Bluebird Bio (BLUE) Stock Down 9% Today?
Tickers BLUE FFIE FUV GS
Tags FUV JPM NASDAQ:BLUE,NYSE:GS,NYSE:JPM,NASDAQ:FUV,NYSE:RDN,NASDAQ:FFIE
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers ATXI BLUE CLXT CYTH
Tags VIVE TPST Benzinga
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers ARBK ATXI BLUE BTCM
Tags MARK POET CYAD
From InvestorPlace
2 Stocks That Could Double Your Money in 2023
Tickers AXSM BLUE
Tags BLUE Recent Press Releases AXSM
From Motley Fool
Newly Approved Drugs In US Command Over $200,000 On An Average
Tickers BLUE QURE
Tags QURE BLUE Health Care
From Benzinga
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
Tickers ARKK BLUE CRSP NTLA
Tags CRSP Recent Press Releases ARKK
From Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
Tickers BLUE CRSP VRTX
Tags Recent Press Releases CRSP BLUE
From Motley Fool
FDA Allows Bluebird Bio To Resume Sickle Cell Disease Studies In Patients Below 18, With Changed Protocol
Tickers BLUE
Tags BLUE Health Care FDA
From Benzinga
BLUE Stock Alert: What to Know as the FDA Lifts Hold on Bluebird Bio Treatment
Tickers BLUE
Tags NASDAQ:BLUE BLUE Market News
From InvestorPlace
Magenta Therapeutics Shares Surge After Encouraging Data From Blood Cancer Candidate At ASH Meeting
Tickers BLUE MGTA
Tags MGTA premarket trading Small Cap
From Benzinga
Why Bluebird Bio Stock Crushed the Market Today
Tickers BLUE
Tags Recent Press Releases BLUE Market News
From Motley Fool
2 Risky Stocks That Could Soar in 2023
Tickers BLUE KRYS
Tags KRYS Market News BLUE
From Motley Fool
Looking Into bluebird bio's Return On Capital Employed
Tickers BLUE
Tags Benzinga Market News Earnings
From Benzinga
Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position
Tickers ARGX BLUE
Tags Market News General Benzinga
From Benzinga
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
Tickers BLUE CSLLY QURE
Tags FDA Small Cap Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.